Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • Child Psychiatry Research T-32 Training Program, Psychiatry, Yale University School of Medicine 1994 - 1995
  • Child and Adolescent Psyuchiatry Fellowship, Psychiatry, Yale University School of Medicine 1992 - 1994
  • General Psychiatry Residency, Psychiatry, Yale University School of Medicine 1989 - 1992
  • MD.M.A., Washington University School of Medicine 1987
• 

  Previous Appointments & Affiliations

  • Instructor Temporary in the Department of Psychiatry and Behavioral Sciences, Psychiatry, Child & Family Mental Health & Community Psychiatry, Psychiatry & Behavioral Sciences 2015 - 2021
• Recognition
• 

  In the News

  • OCT 14, 2021

    Duke Health News

    Hormone Widely Used as an Autism Treatment Shows No Benefit
• Research
• 

  Selected Grants

  • Characterizing the (epi)genetics of oxytocin response in clinical and animal models awarded by National Institutes of Health 2017 - 2023
  • Anti-psychotic Treatment awarded by National Institute for Child Health & Human Develo 2016 - 2021
  • North Carolina Pediatric Access Line for Youth with Intellectual and Developmental Disabilities Family Partner Outreach Project (NC-PAL IDD Family Partner Outreach) awarded by The Arc of North Carolina 2019 - 2021
  • A Phase II multi-center, randomized, double-blind, 24-week, 3-arm, parallel group, placebo-controlled study to investigate the efficacy and safety of RO5285119 in children and adolescents age 5-17 with Autism Spectrum Disorder (ASD) awarded by Roche Biomedical Laboratories 2016 - 2020
  • 1/5-The Autism Biomarkers Consortium for Clinical Trials awarded by Yale University 2015 - 2020
  • Auditory Perception and Emotion Recognition in Young People at Risk for Psychosis awarded by National Institutes of Health 2016 - 2019
  • An Open-Label Extension Study of CM-AT for the Treatment of Children with Autism awarded by Curemark, LLC 2016 - 2019
  • Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B) awarded by National Institutes of Health 2012 - 2018
  • A Multi-Center, Randomized, Double-Blind, 12 Week, Parallel Group, Placebo-Controlled Proof of Concept Study to Investigate the Efficacy and Safety of RO5285119 in Individuals with Autism Spectrum Disorders (ASD) awarded by Roche Biomedical Laboratories 2016 - 2018
  • A Double-Blind Placebo Controlled Study of CM-AT for the Treatment of Autism in Children with All Levels of Fecal Chymotrypsin awarded by Curemark, LLC 2015 - 2018
  • Neural circuits that regulate social motivation awarded by University of North Carolina - Chapel Hill 2013 - 2017
• 

  External Relationships

  • Acadia (note decided not to serve on DSMB, as expected when I completed DCRI COI form for 2021-2022).
  • American Academy of Child and Adolescent Psychiatry
  • Hoffman LaRoche (Roche Holding)
  • Patent application for oxytocin formulation I developed during the course of U01 HD073984 has been recently submitted by Duke Translation and Commercialization Office. If licensed, I might recieve some compensation.
  • The George Washington University
  • University of Massachusetts Amherst
  • University of North Carolina at Chapel Hill
• Scholarly, Clinical, & Service Activities
• 

  Outreach & Engaged Scholarship

  • Summer Neuroscience Program Mentor. Summer Neuroscience Program. 2019  2019

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.